Literature DB >> 21286889

A time course study on prothrombotic parameters and their modulation by anti-platelet drugs in hyperlipidemic hamsters.

Vishal Singh1, Manish Jain, Prem Prakash, Ankita Misra, Vivek Khanna, Rajiv Lochan Tiwari, Ravi Shankar Keshari, Shivendra Singh, Madhu Dikshit, Manoj Kumar Barthwal.   

Abstract

The present study was undertaken to assess the chronology of major pathological events associated with high cholesterol (HC) diet and their modulation by anti-platelet drugs. Male Golden Syrian hamsters were fed HC diet up to 90 days. Plasma lipid, glucose and coagulation parameters (commercial kits), platelet activation (whole blood aggregation and static adhesion), endothelial dysfunction (aortic ring vasoreactivity), splenocyte TNF-α, IFN-γ and iNOS mRNA transcripts (RT-PCR), and ferric chloride (time to occlusion) induced thrombosis were monitored at 15, 30, 60, and 90 days after HC feeding and compared with normolipidemic hamsters. A significant increase in plasma lipid levels was observed at 15 days of HC feeding, but other parameters remain unaltered. Enhanced ADP, collagen, and thrombin-induced platelet aggregation, splenocyte TNF-α expression along with endothelial dysfunction were observed from 30 to 90 days of HC feeding. Platelet adhesion on collagen-/fibrinogen-coated surface and IFN-γ expression were augmented only after 60 days, while enhanced iNOS expression, reduction in thrombin time, and potentiation of ferric chloride-induced thrombosis was observed only at 90 days of HC feeding. Thus, pathological changes induced by HC diet depend on the duration and extent of hyperlipidemia. Moreover, hamsters treated with anti-platelet drugs aspirin (5 mg/kg) or clopidogrel (10 mg/kg) along with HC feeding exhibited reduction in platelet activation as well as subsequent changes observed in the abovementioned parameters following HC feeding. Since reduction in TNF-α was associated with reversion in endothelial dysfunction and prothrombotic state, the role of platelets is implicated in the pathological changes associated with HC feeding.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21286889     DOI: 10.1007/s13105-010-0065-z

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  44 in total

1.  Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS).

Authors:  R Waksman; A E Ajani; R L White; E Pinnow; R Dieble; A B Bui; M Taaffe; L Gruberg; G S Mintz; L F Satler; A D Pichard; K K Kent; J Lindsay
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

2.  A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels.

Authors:  Mami Ikenoya; Yasunobu Yoshinaka; Hideyuki Kobayashi; Katsumi Kawamine; Kimiyuki Shibuya; Fumiyasu Sato; Kimio Sawanobori; Takuya Watanabe; Akira Miyazaki
Journal:  Atherosclerosis       Date:  2006-07-03       Impact factor: 5.162

3.  Modulation of the regression of atherosclerosis in the hamster by dietary lipids: comparison of coconut oil and olive oil.

Authors:  E H Mangiapane; M A McAteer; G M Benson; D A White; A M Salter
Journal:  Br J Nutr       Date:  1999-11       Impact factor: 3.718

4.  Determination of clopidogrel resistance by whole blood platelet aggregometry and inhibitors of the P2Y12 receptor.

Authors:  Boris T Ivandic; Philipp Schlick; Peter Staritz; Kerstin Kurz; Hugo A Katus; Evangelos Giannitsis
Journal:  Clin Chem       Date:  2006-01-19       Impact factor: 8.327

Review 5.  Cytokines in atherosclerosis: pathogenic and regulatory pathways.

Authors:  Alain Tedgui; Ziad Mallat
Journal:  Physiol Rev       Date:  2006-04       Impact factor: 37.312

6.  Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects.

Authors:  Thomas Heitzer; Volker Rudolph; Edzard Schwedhelm; Manuela Karstens; Karsten Sydow; Michelle Ortak; Peter Tschentscher; Thomas Meinertz; Rainer Böger; Stephan Baldus
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-05-04       Impact factor: 8.311

7.  Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome.

Authors:  Andrea Picchi; Xue Gao; Souad Belmadani; Barry J Potter; Marta Focardi; William M Chilian; Cuihua Zhang
Journal:  Circ Res       Date:  2006-06-01       Impact factor: 17.367

8.  Endothelial dysfunction precedes atherosclerotic lesions and platelet activation in high fat diet-induced prothrombotic state.

Authors:  Rumiko Aoki; Hideo Ikarugi; Aki Naemura; Yoshinobu Ijiri; Tsutomu Yamashita; Junichiro Yamamoto
Journal:  Thromb Res       Date:  2006       Impact factor: 3.944

Review 9.  Dual antiplatelet therapy in coronary artery disease: a case-based approach.

Authors:  Chad Raymond; Venu Menon
Journal:  Cleve Clin J Med       Date:  2009-11       Impact factor: 2.321

10.  Antioxidative action of aspirin on endothelial function in hypercholesterolaemic rats.

Authors:  Mohammad Tauseef; Mohd Shahid; Krishna K Sharma; Mohammad Fahim
Journal:  Basic Clin Pharmacol Toxicol       Date:  2008-07-18       Impact factor: 4.080

View more
  3 in total

1.  The IRAK-ERK-p67phox-Nox-2 axis mediates TLR4, 2-induced ROS production for IL-1β transcription and processing in monocytes.

Authors:  Ankita Singh; Vishal Singh; Rajiv L Tiwari; Tulika Chandra; Ashutosh Kumar; Madhu Dikshit; Manoj K Barthwal
Journal:  Cell Mol Immunol       Date:  2015-08-31       Impact factor: 11.530

2.  Curcuma oil ameliorates insulin resistance & associated thrombotic complications in hamster & rat.

Authors:  Vishal Singh; Manish Jain; Ankita Misra; Vivek Khanna; Prem Prakash; Richa Malasoni; Anil Kumar Dwivedi; Madhu Dikshit; Manoj Kumar Barthwal
Journal:  Indian J Med Res       Date:  2015-06       Impact factor: 2.375

3.  A Standardized Chemically Modified Curcuma longa Extract Modulates IRAK-MAPK Signaling in Inflammation and Potentiates Cytotoxicity.

Authors:  Minakshi Rana; Preeti Maurya; Sukka S Reddy; Vishal Singh; Hafsa Ahmad; Anil K Dwivedi; Madhu Dikshit; Manoj K Barthwal
Journal:  Front Pharmacol       Date:  2016-07-25       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.